IACH Junior Club
The “IACH Junior Club” aims to attract the younger generation of new investigators, because this is about bringing new blood into the field and preparing for the future. The IACH Junior Club brings together young colleagues from across the globe to collaborate, share experiences, and most importantly, put a special focus on the “patient-first” approach through discussion of real-life clinical cases. The goal of the IACH Junior Club initiative is to spotlight the work that our younger colleagues, students, residents, fellows, registrars, assistants, etc., are doing every day to help those living with blood diseases. The most complex clinical cases are presented by the younger colleagues and discussed with top experts in the field.
Transient Response with Elranatamab in a Case of Relapsed Refractory Multiple Myeloma with Central Nervous System Involvement
Meral Beksac, Ebrar Uzun
November 19, 2024
Elder Man with Perinephric Fibrosis
Mateo Mejía, Juan Esteban Vélez
August 13, 2024
A Clinical Case About a 34 Year Old Woman With B-ALL Who Developed TMA After HSCT and Was Treated With a Complement Inhibitor
Matina Sourri, Eleni Gavriilaki
June 11, 2024
A Case of a 20 Year Old ALL that Developed a Stroke-Like Syndrome after MTX
David Marks, Simon Nicoletti
March 14, 2024
A Challenging Odyssey through AML: Confronting aGvHD, TMA, PRES after alloHCT
Bhagirathbhai Dholaria, Esra Gulderen
February 8, 2024
Not all Paraproteinemia is Myeloma
Mateo Mejia, Uriel Suarez
November 21, 2023
Use of Cytoreductive Therapy in Patients with Low Risk Polycythemia Vera
Dr. Nikolai Podoltsev, Dr. Jessica Stempel
May 25, 2023
Anti-BCMA Bispecific Antibody for Myeloma Relapse After CAR T Cells
Dr. Nicolas Stocker, Prof. Mohamad Mohty
May 16, 2023
Emergency donor search during the COVID 19 pandemic for a patient with ALL: a case report
Dr. Andrea Acerbis, Dr. Annalisa Ruggeri
April 3, 2023
Management of Older Patients with AML
Prof. Zeidan Amer, Dr. Kewan Tariq
March 22, 2023
Second allogeneic stem cell transplantation as salvage therapy after CAR T cell in high risk acute lymphoblastic leukemia: a case report
Orofino Giorgio, Simona Piemontese, Annalisa Ruggeri, Florent Malard
Feb. 14, 2023
High-risk MDS follonig CAR T cells in patients with RR DLBCL
Thomas Cluzeau, Vera Radici
January 31, 2023
The role of ASCT in AL amyloidosis
Rajshekhar Chakraborty, Lentzsch Suzanne
January 9, 2023
Mantle cell lymphoma case
Shalin Kothari, Faiza Yasin, Florent Malard
November 14, 2022
HLH/HLH-like: a syndrome mimicking HLH after CAR T
October 17, 2022